{
    "thread": {
        "uuid": "4aac3d4dd597658a9e775bce0581cf91525817fe",
        "url": "https://news.knowledia.com/gb/en/articles/orthocell-appoints-first-four-distributors-for-remplir-nerve-repair-797c98afb5d020f9a3a37ff78c646eee4a6a12c7",
        "site_full": "news.knowledia.com",
        "site": "knowledia.com",
        "site_section": "https://news.knowledia.com/gb/en",
        "site_categories": [
            "uncategorized"
        ],
        "section_title": "Knowledia News",
        "site_title": null,
        "title": "Orthocell appoints first four distributors for Remplir nerve repair technology in the US",
        "title_full": "Orthocell appoints first four distributors for Remplir nerve repair technology in the US",
        "published": "2025-04-24T01:03:33.663+03:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "GB",
        "main_image": "",
        "performance_score": 0,
        "domain_rank": 81013,
        "domain_rank_updated": "2025-04-22T00:00:00.000+03:00",
        "licensing_agency": [],
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "4aac3d4dd597658a9e775bce0581cf91525817fe",
    "url": "https://news.knowledia.com/gb/en/articles/orthocell-appoints-first-four-distributors-for-remplir-nerve-repair-797c98afb5d020f9a3a37ff78c646eee4a6a12c7",
    "ord_in_thread": 0,
    "author": "Imelda Cotton",
    "published": "2025-04-24T01:03:33.663+03:00",
    "title": "Orthocell appoints first four distributors for Remplir nerve repair technology in the US",
    "text": "Regenerative medicine company Orthocell (ASX: OCC) has appointed the first four US distributors for the company's flagship nerve repair product Remplir. The move follows regulatory clearance from the US Food and Drug Administration earlier this month, which allowed for immediate distribution into the nation's US$1.6 billion nerve repair market.\nThe four appointees are experienced nerve specialists operating in the states of Michigan, Virginia, Colorado and Indiana.\nNetwork expansion\nThe new distributors will market and sell Remplir across their respective geographic regions, undertaking medical education, targeted promotional activities and initiating sales, as well as expanding the network of referring plastic and orthopaedic surgeons.\nThey will operate on a commission-based structure, supported by a significant Remplir inventory base that Orthocell has built up to meet projected US sales.\nOrthocell expects the sales to drive a significant step change in revenue and provide the company with a pathway to breakeven and profitability.\nPre-launch activities\nManaging director Paul Anderson said the new appointments were the result of extensive pre-launch activities the company's sales, marketing and medical affairs teams conducted in the US.\n\"We have been workingâ€¦\nImelda Cotton",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
        "Health",
        "Science and Technology",
        "Economy, Business and Finance"
    ],
    "topics": [
        "Health->health care approach",
        "Health->health treatment and procedure",
        "Health->health organisation",
        "Science and Technology->technology and engineering",
        "Science and Technology->scientific research",
        "Science and Technology->biomedical science",
        "Economy, Business and Finance->healthcare industry",
        "Economy, Business and Finance->business service"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
        "https://smallcaps.com.au/orthocell-appoints-distributors-remplir-nerve-repair-technology-us/",
        "https://www.smallcaps.com.au/orthocell-appoints-distributors-remplir-nerve-repair-technology-us/",
        "https://smallcaps.com.au/orthocell-appoints-distributors-remplir-nerve-repair-technology-us"
    ],
    "entities": {
        "persons": [
            {
                "name": "Paul Anders",
                "sentiment": "none"
            }
        ],
        "locations": [],
        "organizations": [
            {
                "name": "OCC",
                "sentiment": "negative",
                "tickers": []
            },
            {
                "name": "US Food and Drug Administration",
                "sentiment": "none",
                "tickers": []
            }
        ]
    },
    "syndication": {
        "syndicated": false,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "trust": {
        "categories": [],
        "bias": null,
        "source": {
            "type": null,
            "city": null,
            "state": null,
            "country": null,
            "domain_type": null,
            "agency": null,
            "organization_name": null
        }
    },
    "rating": null,
    "crawled": "2025-04-24T01:03:33.663+03:00",
    "updated": "2025-04-24T01:03:33.663+03:00"
}